Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | CFTR | P13569 | 1/20 | 0.54 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PTGER3 | P43115 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | PYGL | P06737 | 1/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | HTR3A | P46098 | 1/20 | 0.30 |
| ▸ | GJA1 | P17302 | 1/20 | 0.30 |
| ▸ | GJB2 | P29033 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19000673 | 0.87 | USP2 (0.42) | USP2ATML3MBTL1PTGER3FOLH1 | |
| SCHEMBL19000672 | 0.83 | CA12 (0.40) | USP2ATML3MBTL1PTGER3FOLH1 | |
| SCHEMBL19000687 | 0.82 | GBA1 (0.44) | CA12CA1CA2CA9HTR3A | |
| SCHEMBL19000681 | 0.80 | TGM2 (0.43) | USP2 | |
| SCHEMBL19000677 | 0.79 | FTO (0.51) | USP2L3MBTL1MMP1MMP2MMP9 | |
| SCHEMBL27057211 | 0.77 | CA9 (0.45) | USP2ATML3MBTL1PTGER3FOLH1 | |
| SCHEMBL22007229 | 0.77 | FOLH1 (0.43) | USP2ATML3MBTL1PTGER3FOLH1 | |
| SCHEMBL12923622 | 0.76 | ABCB1 (0.75) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL19000694 | 0.75 | USP2 (0.31) | USP2 | |
| SCHEMBL19000671 | 0.74 | USP2 (0.30) | USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3391056-B1 | CHROMOGENIC PEROXIDASE SUBSTRATES | AGILENT TECHNOLOGIES INC (US) | 2024-01-17 | — | — | EP | disclosed |
| US-20230002816-A1 | CHROMOGENIC PEROXIDASE SUBSTRATES | DAKO DENMARK APS (DK) | 2023-01-05 | — | — | US | disclosed |
| US-11466314-B2 | Chromogenic peroxidase substrates | AGILENT TECHNOLOGIES, INC. (US) | 2022-10-11 | — | — | US | disclosed |
| US-20200157613-A1 | CHROMOGENIC PEROXIDASE SUBSTRATES | DAKO DENMARK APS (DK) | 2020-05-21 | — | — | US | disclosed |
| US-20170175178-A1 | CHROMOGENIC PEROXIDASE SUBSTRATES | DAKO DENMARK APS (DK) | 2017-06-22 | — | — | US | disclosed |
| US-20170175178-A1 | CHROMOGENIC PEROXIDASE SUBSTRATES | DAKO DENMARK APS (DK) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170175178-A1 | CHROMOGENIC PEROXIDASE SUBSTRATES | MPO, TPO, TYR | ABCB1 2422/4885USP2 2528/4885CFTR 3630/4885 |
| US-11466314-B2 | Chromogenic peroxidase substrates | MPO, TPO, TYR | ABCB1 2432/4885USP2 2385/4885CFTR 3727/4885 |
| US-20200157613-A1 | CHROMOGENIC PEROXIDASE SUBSTRATES | MPO, TPO, TYR | ABCB1 2432/4885USP2 2385/4885CFTR 3727/4885 |
| US-20230002816-A1 | CHROMOGENIC PEROXIDASE SUBSTRATES | MPO, TPO, TYR | ABCB1 2432/4885USP2 2385/4885CFTR 3727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.